Table 1 Baseline characteristics of enrolled patients
Variables | HPSD group (n = 50) | Conventional group (n = 50) |
|---|---|---|
Age (years, IQR) | 63 (52–70) | 63 (55–70) |
Male (n, %) | 27 (54%) | 33 (66%) |
BMI (kg/m2, IQR) | 24.2 (22.0–26.4) | 24.1 (22.2–26.3) |
Smoking (n, %) | 16 (32%) | 21 (42%) |
Drinking (n, %) | 11 (22%) | 19 (38%) |
CHA2DS2-VASc score (points, IQR) | 1.5 (1–3) | 2.0 (1–3) |
MoCA score (points, IQR) | 26.0 (22.0–27.3) | 25.5 (22.0–28.0) |
AF classification | ||
 Paroxysmal (n, %) | 33 (66%) | 26 (52%) |
 Persistent (n, %) | 17 (34%) | 24 (48%) |
Echocardiography | ||
 LAD (mm, mean ± SD) | 37.5 ± 4.0 | 38.9 ± 5.3 |
 LVEF (%, IQR) | 66.0 (61.7–71.0) | 66.0 (63.0–72.0) |
Comorbidities | ||
 Hypertension (n, %) | 22 (44%) | 25 (50%) |
 Coronary artery disease (n, %) | 6 (12%) | 17 (34%) |
 Diabetes mellitus (n, %) | 6 (12%) | 7 (14%) |
 Heart failure (n, %) | 2 (4%) | 2 (4%) |
 Stroke/TIA (including lacunar infarct, n, %) | 7 (14%) | 7 (14%) |
 Hyperlipidemia (n, %) | 11 (22%) | 13 (26%) |
Laboratory test | ||
 NT-proBNP level (pg/ml, IQR) | 226.3 (74.9–881.6) | 421.3 (125.4–922.3) |
 Creatinine (mmol/L, IQR) | 70.1 (62.0–84.7) | 72.2 (61.8–86.5) |